HK1199249A1 - 含有並環的噁唑烷酮類抗菌素 - Google Patents

含有並環的噁唑烷酮類抗菌素

Info

Publication number
HK1199249A1
HK1199249A1 HK14112747.5A HK14112747A HK1199249A1 HK 1199249 A1 HK1199249 A1 HK 1199249A1 HK 14112747 A HK14112747 A HK 14112747A HK 1199249 A1 HK1199249 A1 HK 1199249A1
Authority
HK
Hong Kong
Prior art keywords
fused ring
containing fused
antibiotics containing
oxazolidinone antibiotics
oxazolidinone
Prior art date
Application number
HK14112747.5A
Other languages
English (en)
Inventor
張蕙
王愛臣
Original Assignee
Xuanzhu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xuanzhu Pharma Co Ltd filed Critical Xuanzhu Pharma Co Ltd
Publication of HK1199249A1 publication Critical patent/HK1199249A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK14112747.5A 2011-09-30 2014-12-19 含有並環的噁唑烷酮類抗菌素 HK1199249A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110291417 2011-09-30
PCT/CN2012/082422 WO2013044865A1 (zh) 2011-09-30 2012-09-29 含有并环的噁唑烷酮类抗菌素

Publications (1)

Publication Number Publication Date
HK1199249A1 true HK1199249A1 (zh) 2015-06-26

Family

ID=47994281

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112747.5A HK1199249A1 (zh) 2011-09-30 2014-12-19 含有並環的噁唑烷酮類抗菌素

Country Status (6)

Country Link
US (1) US9487545B2 (zh)
EP (1) EP2762480A4 (zh)
JP (1) JP5833764B2 (zh)
CN (1) CN103030634B (zh)
HK (1) HK1199249A1 (zh)
WO (1) WO2013044865A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2762480A4 (en) 2011-09-30 2015-03-18 Xuanzhu Pharma Co Ltd OXAZOLIDINONIBIOTICS WITH CONDENSED RINGS
CN104177373A (zh) * 2013-05-22 2014-12-03 中国医学科学院医药生物技术研究所 抗结核化合物imb-cc223
CN105503955B (zh) * 2014-10-15 2018-11-20 正大天晴药业集团股份有限公司 一种抗革兰氏阳性菌的化合物的制备方法
CN105418678B (zh) * 2014-09-17 2018-11-20 正大天晴药业集团股份有限公司 一种磷酸特地唑胺的制备方法
CN106928214A (zh) * 2014-09-17 2017-07-07 博瑞生物医药（苏州）股份有限公司 一种噁唑烷酮类化合物及其中间体的制备方法
CN105837633B (zh) * 2015-01-12 2018-11-20 正大天晴药业集团股份有限公司 一种抗菌化合物的制备方法
CN105566392B (zh) * 2014-10-15 2018-12-21 正大天晴药业集团股份有限公司 一种细菌蛋白质合成抑制剂的制备方法
CN106045934A (zh) * 2015-10-27 2016-10-26 博瑞生物医药（苏州）股份有限公司 一种合成泰地唑胺的中间体的晶型
GB201604638D0 (en) * 2016-03-18 2016-05-04 Mission Therapeutics Ltd Novel compounds
GB201604647D0 (en) 2016-03-18 2016-05-04 Mission Therapeutics Ltd Novel compounds
EP3601233B1 (en) * 2017-03-27 2024-08-14 Hydro-Québec Salts for use in electrolyte compositions or as electrode additives
CN112543756A (zh) 2018-07-25 2021-03-23 卡迪拉保健有限公司 用于治疗哺乳动物感染的经取代噁唑烷酮类
CN111349059B (zh) * 2018-12-20 2023-03-31 中国科学院上海药物研究所 一类手性环氧化合物的制备方法
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections
CN112047937B (zh) * 2019-06-06 2023-04-07 劲方医药科技(上海)有限公司 四氢吡啶并[3,4-d]嘧啶-2(1H)-酮类化合物，其制法与医药上的用途
US20220274982A1 (en) 2019-07-29 2022-09-01 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2022135601A1 (zh) * 2020-12-25 2022-06-30 杭州百新生物医药科技有限公司 5-烷基-2-吡唑-恶唑烷-4-酮类衍生物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204874T1 (de) 1995-05-11 2001-09-15 Upjohn Co Spirocyclische und bicyclische diazinyl- und carbazinyloxazolidinone
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
JP2004518724A (ja) * 2001-02-07 2004-06-24 オーソーマクニール ファーマシューティカル， インコーポレイテッド ピリドアリールフェニル・オキサゾリジノン抗菌剤、および関連の組成物および方法
EP2009012B1 (en) * 2006-03-31 2014-06-25 Research Foundation Itsuu Laboratory Novel compound having heterocyclic ring
US8575337B2 (en) 2008-06-24 2013-11-05 Research Foundation Itsuu Laboratory Oxazolidinone derivative having fused ring
CN102153547A (zh) * 2010-02-11 2011-08-17 山东轩竹医药科技有限公司 含有并环的噁唑烷酮抗菌素
CN102190656B (zh) * 2010-03-16 2014-03-26 山东轩竹医药科技有限公司 含有五元杂环的噁唑烷酮抗菌素
EP2762480A4 (en) 2011-09-30 2015-03-18 Xuanzhu Pharma Co Ltd OXAZOLIDINONIBIOTICS WITH CONDENSED RINGS

Also Published As

Publication number Publication date
CN103030634A (zh) 2013-04-10
US20140243288A1 (en) 2014-08-28
EP2762480A1 (en) 2014-08-06
JP2014530207A (ja) 2014-11-17
EP2762480A4 (en) 2015-03-18
JP5833764B2 (ja) 2015-12-16
US9487545B2 (en) 2016-11-08
CN103030634B (zh) 2015-07-15
WO2013044865A1 (zh) 2013-04-04

Similar Documents

Publication Publication Date Title
HK1199249A1 (zh) 含有並環的噁唑烷酮類抗菌素
ZA201406833B (en) Fused bicyclic oxazolidinone cetp inhibitor
HK1204457A1 (zh) 樞轉環密封
EP2765339A4 (en) WATERTIGHT RING
IL227252A0 (en) Aminodihydrothiazine history from sisterhood
ZA201304207B (en) Indeno-fused ring compounds
GB201101140D0 (en) Fused aminodihydrothiazine derivatives
AU338472S (en) Cap
GB201200835D0 (en) Lenses
EP2586325A4 (en) RING WITH ADJUSTABLE INTERNAL DIAMETER
EP2719928A4 (en) WATERTIGHT RING
ZA201401922B (en) Universal Ring Free
EP2749922A4 (en) lens
PL2671011T3 (pl) Pierścień zaciskowy
AU341024S (en) Cap
ZA201300572B (en) Fused ring pyridine compound
EP2653756A4 (en) SEAL RING
AU341012S (en) Cap
EP2713728A4 (en) NEW ANTIBIOTICS
GB2494036B (en) Retaining ring configuration system
GB201122453D0 (en) Lens cap
GB201107175D0 (en) Teething ring
HUP1100252A2 (en) Fixing double ring
AU2011902508A0 (en) Pacifier Holder
PL2683969T3 (pl) Uszczelnienie pierścieniem ślizgowym